Please login to the form below

Not currently logged in
Email:
Password:

marketing practices

This page shows the latest marketing practices news and features for those working in and with pharma, biotech and healthcare.

Reckitt hammered by $1.4bn opioid settlement bill

Reckitt hammered by $1.4bn opioid settlement bill

Case centres on Subaxone marketing practices. Reckitt Benckiser (RB) has agreed to pay an eye-watering $1.4bn to the US government to resolve criminal and civil litigation over the marketing ... The federal investigation centred on a former Reckitt

Latest news

More from news
Approximately 1 fully matching, plus 82 partially matching documents found.

Latest Intelligence

  • Cutting through the noise

    Physicians want to:. Maintain knowledge of best practices or learn about new developments in their field. ... Getting close. In recent years we have explored how best practices in marketing communications can be extended to medical education.

  • Delivering ‘accountable marketing’ Delivering ‘accountable marketing

    It’s about time… and data. A heightened sense of urgency is stoking corporate interest in ‘accountable marketing’ practices. ... At a strategic level, we can no longer simply articulate what marketing campaign objectives are.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics